Home › Funds › Citigroup Inc › BCAB
Citigroup Inc position in BCAB
BIOATLA INC · Materials
Latest position (Q3 2025)26.13K sh
Reported value held$17.98K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 26.90K | $792.00K | New |
| Q4 2021 | 70.59K | $1.39M | Add |
| Q1 2022 | 4.17K | $21.00K | Reduce |
| Q2 2022 | 1.46K | $4.00K | Reduce |
| Q3 2022 | 2.39K | $18.00K | Add |
| Q4 2022 | 40.88K | $337.23K | Add |
| Q1 2023 | 527 | $1.41K | Reduce |
| Q2 2023 | 13.98K | $41.94K | Add |
| Q3 2023 | 618 | $1.05K | Reduce |
| Q4 2023 | 6.57K | $16.15K | Add |
| Q1 2024 | 8.37K | $28.81K | Add |
| Q2 2024 | 6.24K | $8.55K | Reduce |
| Q3 2024 | 6.03K | $10.60K | Reduce |
| Q4 2024 | 6.43K | $3.80K | Add |
| Q3 2025 | 26.13K | $17.98K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BCAB
- Vanguard Group 1.95M sh · $1.11M · Q4 2025
- Millennium Management 70.62K sh · $292.35K · Q2 2026
- Geode Capital Management 12.82K sh · $53.08K · Q2 2026
- Deutsche Bank AG 10.56K sh · $43.70K · Q2 2026
- BlackRock Inc 9.62K sh · $39.81K · Q2 2026
- UBS Group AG 6.20K sh · $25.67K · Q2 2026
- Morgan Stanley 1.11K sh · $4.59K · Q2 2026
- JPMorgan Chase & Co 121 sh · $464 · Q2 2026